Company profile: Kayentis
1.1 - Company Overview
Company description
- Provider of eCOA and Decentralized Clinical Trial solutions that streamline clinical trial data collection and quality for pharma, biotech, and CROs. Offers Clin'form platform, app, web portal, and Connect for at-home/on-site capture, multi-mode entry, real-time monitoring, interoperability with EDC/CDMS, and integration with medical devices and wearables, plus project and data management services. Active since 2005 across phases I–IV and 200+ indications.
Products and services
- Clin'form App: A multi-modal application that captures clinical trial data through Provisioned Devices, BYOD, WebCOA, and remote interviews, enabling device-based, browser-based, and interviewer-led data entry
- Clin'form Web Portal: An interoperable web interface for sponsors and site staff to monitor and manage trial data in real time, offering EDC/CDMS interoperability and built-in data management
- Clin'form: An enterprise-grade eCOA platform that collects and manages study data for at-home and on-site trials, boosting patient engagement and trial efficiency across phases I–IV
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kayentis
Activiomics
HQ: United Kingdom
Website
- Description: Provider of phosphoproteomics solutions for biomarker discovery, diagnostics development, and drug candidate identification and profiling, leveraging patented, novel mass spectrometry-based approaches.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Activiomics company profile →
Allcyte
HQ: Austria
Website
- Description: Provider of functional drug testing in primary human material using the Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines to advance precision and personalized medicine for cancer patients and treating physicians, while supporting pharmaceutical companies in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allcyte company profile →
Enterome
HQ: France
Website
- Description: Provider of clinical-stage immunomodulatory drugs for cancer and immune diseases, offering OncoMimics, a cancer immunotherapy using bacterial peptides to mimic tumor antigens, with Phase 2 candidates EO2401 (glioblastoma/adrenal), EO2463 (indolent NHL) and EO4010 (third-line colorectal), and EndoMimics oral bioactives for inflammatory/autoimmune diseases, including EB1010 for food allergies and IBD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enterome company profile →
BEKHealth
HQ: United States
Website
- Description: Provider of AI-powered chart abstraction and patient-matching solutions that analyze structured and unstructured EMR data to optimize clinical trial enrollment. Services include an automated ETL pipeline via proprietary EMR adapters, an AI data platform to standardize and translate medical data, patient matching, study rescue, and sponsor–site matching.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BEKHealth company profile →
Roam Analytics
HQ: United States
Website
- Description: Provider of a proprietary artificial intelligence platform for healthcare that transforms patient and physician pathway analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roam Analytics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kayentis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kayentis
2.2 - Growth funds investing in similar companies to Kayentis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kayentis
4.2 - Public trading comparable groups for Kayentis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →